HELPLINE: 0800 4 PROSTATE (0800 477 678)



Our Mission

To provide an environment empowering men to make informed decisions about the diagnosis and treatment of prostate cancer.

Throughout New Zealand, we offer peer support to men, and their families, who have been diagnosed with prostate cancer, and we actively promote awareness of this disease through community promotions, including our Blue September campaign month.

Sexual Health Study

One in three men have concerns about their sexual health (e.g. erectile dysfunction) after prostate cancer treatment. Many men are reluctant to get help for their sexual concerns, and when they do, often men do not continue with treatment.

The Men and Sexual Health – Prostate Cancer study is an online survey that will take approximately 30 to 40 minutes of your time.

If you are aged over 18 years, have been diagnosed with Prostate Cancer and would like to share your experience and help other men affected, please visit

More on this story.

Seeking Patient Feedback

In early September 2016, Graeme Pollard was told he has inoperable prostate cancer and it has probably spread to other parts of his body.

When Pollard turned 50 he was advised by friends to get a prostate check. The tests include a blood test for prostate specific antigen (PSA) and a digital rectal examination (DRE).

His GP told him he was low-risk and the tests were unnecessary.

Pollard asked another GP for a prostate check two years ago.

He was again told the tests were unnecessary.

More on this story.

Have you had a similar experience? The Prostate Cancer Foundation would like to hear from you. Please click here to leave your comments.

Latest News

Simple check could save lives, Auckland prostate cancer survivor says

Reluctance and fear is holding men back from having life-saving tests, according to prostate cancer survivor Kevin Brailey. The North Shore insurance brokerage owner wants to raise awareness about prostate cancer and encourage more men to get checked. Brailey, who is in his 60s, was diagnosed with prostate cancer in 2012. He credits his GP…

Kiwi men set to benefit from better prostate cancer diagnosis

F-18 PSMA is a radioactive tracer that can pinpoint tiny cancer cells otherwise missed on conventional scans. The technology will help doctors identify early if prostate cancer has returned, and where, potentially improving outcomes for patients.